Stable profits, low leverage to keep credit profiles comfortable
This license will enable Abbott to enhance access to this novel therapy to more patients across India
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Subscribe To Our Newsletter & Stay Updated
